Hybio Pharmaceutical Co., Ltd. Class A · SZSE:300199

Hybio Pharmaceutical Co., Ltd. Class A shareholders

Hybio Pharmaceutical Co., Ltd. Class A on 6ix: holders from US fund reports. Largest: Vanguard Total International Stock Index Fund, Vanguard Emerging Markets Stock Index Fund and Vanguard Ftse All-World Ex-Us Small-Cap Index Fund. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund885KUS$2.76MNo changeJul 31, 2026
Vanguard Emerging Markets Stock Index Fund803KUS$2.51MNo changeJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund240KUS$750KNo changeJul 31, 2026
Dimensional Emerging Core Equity Market ETF60,400US$189K+18,000Jul 31, 2026
The Emerging Markets Series52,300US$163KNewJul 31, 2026
Vanguard Total World Stock Index Fund43,100US$135KNo changeJul 31, 2026
Emerging Markets Core Equity 2 Portfolio27,900US$87,116No changeJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF8,800US$27,494NewJul 31, 2026
Dimensional Emerging Markets High Profitability ETF400US$1,250NewJul 31, 2026

Hybio Pharmaceutical Co., Ltd. Class A insider trades